Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03999268 · ClinicalTrials.gov registry record · NA
Insulin Start Therapy Application With Resources and Training
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT03999268 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 41 participants.
The verdict
NCT03999268, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of the I-START study is to evaluate an educational phone application (app) designed to support patients with type 2 diabetes (T2DM) by reinforcing the necessary skills needed for insulin administration as part of diabetes self-management.
Interventions
- BEHAVIORAL I-START
- BEHAVIORAL Standard Insulin Administration Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2019-11-25 |
| Est. Completion | 2022-05-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03999268
The ClinicalTrials.gov registry entry for NCT03999268 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which I-START is the first listed.
NCT03999268 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03999268 about?
NCT03999268 is a clinical study titled "Insulin Start Therapy Application With Resources and Training". The purpose of the I-START study is to evaluate an educational phone application (app) designed to support patients with type 2 diabetes (T2DM) by reinforcing the necessary skills needed for insulin administration as part of diabetes self-management.
What is the current status of trial NCT03999268?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2019-11-25. Estimated completion is 2022-05-25.
What interventions are being tested in trial NCT03999268?
The interventions under investigation include: I-START (BEHAVIORAL), Standard Insulin Administration Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT03999268?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.